Literature DB >> 25704759

Assessing the osteoblast transcriptome in a model of enhanced bone formation due to constitutive Gs-G protein signaling in osteoblasts.

Lalita Wattanachanya1, Liping Wang2, Susan M Millard3, Wei-Dar Lu4, Dylan O'Carroll5, Edward C Hsiao6, Bruce R Conklin7, Robert A Nissenson8.   

Abstract

G protein-coupled receptor (GPCR) signaling in osteoblasts (OBs) is an important regulator of bone formation. We previously described a mouse model expressing Rs1, an engineered constitutively active Gs-coupled GPCR, under the control of the 2.3 kb Col I promoter. These mice showed a dramatic age-dependent increase in trabecular bone of femurs. Here, we further evaluated the effects of enhanced Gs signaling in OBs on intramembranous bone formation by examining calvariae of 1- and 9-week-old Col1(2.3)/Rs1 mice and characterized the in vivo gene expression specifically occurring in osteoblasts with activated Gs G protein-coupled receptor signaling, at the cellular level rather than in a whole bone. Rs1 calvariae displayed a dramatic increase in bone volume with partial loss of cortical structure. By immunohistochemistry, Osterix was detected in cells throughout the inter-trabecular space while Osteocalcin was expressed predominantly in cells along bone surfaces, suggesting the role of paracrine mediators secreted from OBs driven by 2.3 kb Col I promoter could influence early OB commitment, differentiation, and/or proliferation. Gene expression analysis of calvarial OBs revealed that genes affected by Rs1 signaling include those encoding proteins important for cell differentiation, cytokines and growth factors, angiogenesis, coagulation, and energy metabolism. The set of Gs-GPCRs and other GPCRs that may contribute to the observed skeletal phenotype and candidate paracrine mediators of the effect of Gs signaling in OBs were also determined. Our results identify novel detailed in vivo cellular changes of the anabolic response of the skeleton to Gs signaling in mature OBs. Published by Elsevier Inc.

Entities:  

Keywords:  G protein coupled receptor (GPCR); Gene expression analysis; Intramembranous bone; Mouse model; Osteoblasts (OBs); Paracrine mediators

Mesh:

Substances:

Year:  2015        PMID: 25704759      PMCID: PMC4408231          DOI: 10.1016/j.yexcr.2015.02.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  45 in total

1.  A single mutation in the 5-HT4 receptor (5-HT4-R D100(3.32)A) generates a Gs-coupled receptor activated exclusively by synthetic ligands (RASSL).

Authors:  Sylvie Claeysen; Lara Joubert; Michèle Sebben; Joël Bockaert; Aline Dumuis
Journal:  J Biol Chem       Date:  2002-11-18       Impact factor: 5.157

Review 2.  Differentiation of osteoblasts and osteocytes from mesenchymal stem cells.

Authors:  Terhi J Heino; Teuvo A Hentunen
Journal:  Curr Stem Cell Res Ther       Date:  2008-05       Impact factor: 3.828

3.  Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone.

Authors:  L M Calvi; N A Sims; J L Hunzelman; M C Knight; A Giovannetti; J M Saxton; H M Kronenberg; R Baron; E Schipani
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

4.  Col1a1-driven transgenic markers of osteoblast lineage progression.

Authors:  S Dacic; I Kalajzic; D Visnjic; A C Lichtler; D W Rowe
Journal:  J Bone Miner Res       Date:  2001-07       Impact factor: 6.741

5.  High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study.

Authors:  Georg Schett; Stefan Kiechl; Siegfried Weger; Angelo Pederiva; Agnes Mayr; Manuele Petrangeli; Friedrich Oberhollenzer; Rolando Lorenzini; Kurt Redlich; Roland Axmann; Jochen Zwerina; Johann Willeit
Journal:  Arch Intern Med       Date:  2006 Dec 11-25

6.  Identification of differentially expressed genes between osteoblasts and osteocytes.

Authors:  Frane Paic; John C Igwe; Ravi Nori; Mark S Kronenberg; Tiziana Franceschetti; Patrick Harrington; Lynn Kuo; Dong-Guk Shin; David W Rowe; Stephen E Harris; Ivo Kalajzic
Journal:  Bone       Date:  2009-06-17       Impact factor: 4.398

7.  The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response.

Authors:  Ni Wang; Thusanth Thuraisingam; Lucia Fallavollita; Aihao Ding; Danuta Radzioch; Pnina Brodt
Journal:  Cancer Res       Date:  2006-03-15       Impact factor: 12.701

Review 8.  Coagulation meets calcification: the vitamin K system.

Authors:  Thilo Krueger; Ralf Westenfeld; Leon Schurgers; Vincent Brandenburg
Journal:  Int J Artif Organs       Date:  2009-02       Impact factor: 1.595

9.  Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+.

Authors:  P Lehenkari; T A Hentunen; T Laitala-Leinonen; J Tuukkanen; H K Väänänen
Journal:  Exp Cell Res       Date:  1998-07-10       Impact factor: 3.905

10.  Insights in to the pathogenesis of axial spondyloarthropathy based on gene expression profiles.

Authors:  Srilakshmi M Sharma; Dongseok Choi; Stephen R Planck; Christina A Harrington; Carrie R Austin; Jinnell A Lewis; Tessa N Diebel; Tammy M Martin; Justine R Smith; James T Rosenbaum
Journal:  Arthritis Res Ther       Date:  2009-11-09       Impact factor: 5.156

View more
  1 in total

1.  Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened Osteoanabolism.

Authors:  Yu Shao; Selene Hernandez-Buquer; Paul Childress; Keith R Stayrook; Marta B Alvarez; Hannah Davis; Lilian I Plotkin; Yongzheng He; Keith W Condon; David B Burr; Stuart J Warden; Alexander G Robling; Feng-Chun Yang; Ronald C Wek; Matthew R Allen; Joseph P Bidwell
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.